AVTR
vs
S&P 500
AVTR
S&P 500
Over the past 12 months, AVTR has underperformed S&P 500, delivering a return of -47% compared to the S&P 500's +16% growth.
Stocks Performance
AVTR vs S&P 500
Performance Gap
AVTR vs S&P 500
Performance By Year
AVTR vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Avantor Inc
Glance View
Avantor Inc. is a unique force in the world of life sciences, a field where precision and reliability are as vital as oxygen to human existence. This Pennsylvania-based corporation manages to weave a complex tapestry of innovation and efficiency in its mission to support scientific advancement across the globe. Avantor operates within a diverse landscape, offering a vast array of products that cater to a wide spectrum of industries, including biotechnology, pharmaceutical, healthcare, industrial, and applied materials. At its core, the company functions as a crucial provider of high-purity materials, customized solutions, and highly specialized services that researchers, scientists, and professionals rely on daily to push the boundaries of what's possible. Avantor makes its money through its strategic integration of manufacturing high-quality laboratory and production materials with a comprehensive distribution network. The company boasts a robust catalog of over six million products, including chemicals, reagents, and other essential laboratory supplies. By leveraging its expansive reach and deep-rooted presence in over 30 countries, Avantor efficiently links product innovation with customer needs. Their operations are not merely transactional but are deeply embedded with a service-oriented approach, ensuring that they not only meet the diverse needs of their clients but also continually innovate to help advance scientific breakthroughs. Profitability stems from both the direct sale of products and long-term service agreements, which foster enduring partnerships and create a strong revenue stream, reinforcing Avantor's stature as a pillar in the life sciences sector.
